{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:06:56Z","timestamp":1753888016874},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,30]]},"DOI":"10.7759\/cureus.25491","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T16:17:20Z","timestamp":1653927440000},"source":"Crossref","is-referenced-by-count":1,"title":["Myxedema Secondary to Levothyroxine Malabsorption in Newly Diagnosed Celiac Disease"],"prefix":"10.7759","author":[{"given":"Brandon","family":"Wiggins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle T","family":"Knight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fady","family":"Banno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Minaudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2015.09.011","article-title":"Celiac disease detection in hypothyroid patients requiring elevated thyroid supplementation: a prospective cohort study","volume":"26","author":"Zubarik R","year":"2015","unstructured":"Zubarik R, Ganguly E, Nathan M, Vecchio J. Celiac disease detection in hypothyroid patients requiring elevated thyroid supplementation: a prospective cohort study. Eur J Intern Med. 2015, 26:825-829. 10.1016\/j.ejim.2015.09.011","journal-title":"Eur J Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/nu12061769","article-title":"Thyroid-gut-axis: how does the microbiota influence thyroid function?","volume":"12","author":"Knezevic J","year":"2020","unstructured":"Knezevic J, Starchl C, Tmava Berisha A, Amrein K. Thyroid-gut-axis: how does the microbiota influence thyroid function?. Nutrients. 2020, 12:1769. 10.3390\/nu12061769","journal-title":"Nutrients"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nm0698-713","article-title":"Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease","volume":"4","author":"Molberg O","year":"1998","unstructured":"Molberg O, Mcadam SN, K\u00f6rner R, et al.. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med. 1998, 4:713-717. 10.1038\/nm0698-713","journal-title":"Nat Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.09.003","article-title":"Celiac disease and hypothyroidism","volume":"125","author":"Collins D","year":"2012","unstructured":"Collins D, Wilcox R, Nathan M, Zubarik R. Celiac disease and hypothyroidism. Am J Med. 2012, 125:278-282. 10.1016\/j.amjmed.2011.09.003","journal-title":"Am J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3121\/cmr.2007.738","article-title":"Celiac disease and autoimmune thyroid disease","volume":"5","author":"Ch'ng CL","year":"2007","unstructured":"Ch'ng CL, Jones MK, Kingham JGC. Celiac disease and autoimmune thyroid disease. Clin Med Res. 2007, 5:184-92. 10.3121\/cmr.2007.738","journal-title":"Clin Med Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0798","article-title":"Risk of thyroid disease in individuals with celiac disease","volume":"93","author":"Elfstr\u00f6m P","year":"2008","unstructured":"Elfstr\u00f6m P, Montgomery SM, K\u00e4mpe O, Ekbom A, Ludvigsson JF. Risk of thyroid disease in individuals with celiac disease. J Clin Endocrinol Metab. 2008, 93:3915-3921. 10.1210\/jc.2008-0798","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/BF02232684","article-title":"Myxedema and intestinal malabsorption (nontropical sprue?) with severe hypomotility of the gastrointestinal tract: report of a case","volume":"9","author":"Kelley ML Jr","year":"1964","unstructured":"Kelley ML Jr, Stewart JM. Myxedema and intestinal malabsorption (nontropical sprue?) with severe hypomotility of the gastrointestinal tract: report of a case. Am J Dig Dis. 1964, 9:79-86. 10.1007\/BF02232684","journal-title":"Am J Dig Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/0885066607301361","article-title":"Myxedema coma","volume":"22","author":"Kwaku MP","year":"2007","unstructured":"Kwaku MP, Burman KD. Myxedema coma. J Intensive Care Med. 2007, 22:224-231. 10.1177\/0885066607301361","journal-title":"J Intensive Care Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000100501","article-title":"Two common reasons of malabsorption syndromes: celiac disease and Whipple's disease","volume":"74","author":"Sun DF","year":"2006","unstructured":"Sun DF, Fang JY. Two common reasons of malabsorption syndromes: celiac disease and Whipple's disease. Digestion. 2006, 74:174-183. 10.1159\/000100501","journal-title":"Digestion"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.007","article-title":"Hashimoto thyroiditis: clinical and diagnostic criteria","volume":"13","author":"Caturegli P","year":"2014","unstructured":"Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014, 13:391-397. 10.1016\/j.autrev.2014.01.007","journal-title":"Autoimmun Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-02185-4","article-title":"Prevalence of gastrointestinal disorders having an impact on tablet levothyroxine absorption: should this formulation still be considered as the first-line therapy?","volume":"67","author":"Castellana M","year":"2020","unstructured":"Castellana M, Castellana C, Giovanella L, Trimboli P. Prevalence of gastrointestinal disorders having an impact on tablet levothyroxine absorption: should this formulation still be considered as the first-line therapy?. Endocrine. 2020, 67:281-290. 10.1007\/s12020-019-02185-4","journal-title":"Endocrine"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1306","article-title":"Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases","volume":"90","author":"Santini F","year":"2005","unstructured":"Santini F, Pinchera A, Marsili A, et al.. Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases. J Clin Endocrinol Metab. 2005, 90:124-127. 10.1210\/jc.2004-1306","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/97613-myxedema-secondary-to-levothyroxine-malabsorption-in-newly-diagnosed-celiac-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:00Z","timestamp":1707507360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/97613-myxedema-secondary-to-levothyroxine-malabsorption-in-newly-diagnosed-celiac-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,30]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.25491","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,30]]}}}